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Abstract 1 
Overfeeding experiments, in which we impose short-term positive energy balance, 2 
help unravel the cellular, physiological and behavioural adaptations to nutrient excess. 3 
These studies mimic longer-term mismatched energy expenditure and intake. There is 4 
considerable inter-individual heterogeneity in the magnitude of weight gain when 5 
exposed to similar relative caloric excess reflecting variable activation of 6 
compensatory adaptive mechanisms. Significantly, given similar relative weight gain, 7 
individuals may be protected from/predisposed to metabolic complications (insulin 8 
resistance, dyslipidaemia, hypertension), non-alcoholic fatty liver disease and 9 
cardiovascular disease. Similar mechanistic considerations underpinning the 10 
heterogeneity of overfeeding responses are pertinent in understanding emerging 11 
metabolic phenotypes e.g. metabolically unhealthy normal weight and metabolically 12 
healthy obesity.  13 
Intrinsic and extrinsic factors modulate individuals’ overfeeding response: intrinsic 14 
factors include gender/hormonal status, genetic/ethnic background, baseline metabolic 15 
health and cardiorespiratory fitness; extrinsic factors include macronutrient (fat vs. 16 
carbohydrate) content, fat/carbohydrate composition and overfeeding pattern. 17 
Subcutaneous adipose tissue (SAT) analysis, coupled with metabolic assessment, with 18 
overfeeding have revealed how SAT remodels to accommodate excess nutrients. SAT 19 
remodelling occurs either by hyperplasia (increased adipocyte number) or by 20 
hypertrophy (increased adipocyte size). Biological responses of SAT also govern the 21 
extent of ectopic (visceral/liver) triglyceride deposition. Body composition analysis 22 
by DEXA/MRI have determined the relative expansion of SAT (including 23 
abdominal/gluteofemoral SAT) versus ectopic fat with overfeeding.  24 
Such studies have contributed to the adipose expandability hypothesis whereby SAT 25 
 3
has a finite capacity to expand (governed by intrinsic biological characteristics) and 1 
once capacity is exceeded ectopic triglyceride deposition occurs. The potential for 2 
SAT expandability confers protection from/predisposes to the adverse metabolic 3 
responses to over-feeding. The concept of a personal fat threshold suggests a large 4 
inter-individual variation in SAT capacity with ectopic depot expansion/metabolic 5 
decompensation once one’s own threshold is exceeded.  6 
This review summarises insight gained from overfeeding studies regarding 7 
susceptibility to obesity and related complications with nutrient excess.  8 
 9 
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 1 
Introduction   2 
Long-term regulation and maintenance of body weight and body composition relies 3 
upon integrated systems controlling energy intake, energy expenditure, substrate 4 
utilisation and partitioning among different metabolic tissues and pathways. 5 
Peripheral signals released from the gastrointestinal tract and adipose tissue integrate 6 
within the hypothalamus to regulate energy intake and energy expenditure. Fat-free 7 
mass, through the resting metabolic rate, also regulates energy intake. It has been 8 
proposed that body weight is maintained at a ‘set-point’ and that deviations from this 9 
point (with negative or positive energy balance) are countered and minimised by 10 
feedback mechanisms involving compensatory changes in appetite and energy 11 
expenditure1, 2.  12 
Obesity represents a state of energy imbalance created by mismatched energy 13 
expenditure with disproportionally low physical activity coupled with increased 14 
energy intake (i.e. nutrient excess). However, individuals subjected to a similar 15 
relative positive energy balance show considerable heterogeneity in the extent to 16 
which their body weight or body composition is altered. When faced with energy 17 
excess, only 300-500g of carbohydrate can be stored as glycogen, thus any excess 18 
energy must either be oxidized or converted to triglyceride. In contrast to the other 19 
macronutrients, there is a virtually unlimited storage capacity for triglyceride within 20 
adipose tissue. Thus, body weight increase occurs predominantly via increased 21 
adipose tissue volume with a small increase in fat-free mass3.   22 
There is abundant information on weight loss (achieved in many different ways) but 23 
much less information on controlled weight gain. Overfeeding experiments in which 24 
we mimic a state of (at least) short-term energy surplus have facilitated our 25 
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understanding of the adaptive cellular, physiological and behavioral responses of 1 
adipose tissue and other organs (e.g. liver, skeletal muscle and brain) to weight gain 2 
and helped explain the inter-individual heterogeneity to weight gain.  These studies 3 
have also provided insight into susceptibility to metabolic decompensation with 4 
weight gain. For ethical reasons, these studies are usually short- to medium-term, 5 
ranging in duration from <24 hours to 8-12 weeks.  6 
 7 
Review Methodology 8 
This is a narrative review, however, to ensure all relevant literature is considered, 9 
systematic searches were carried out on Medline and Scopus using the terms 10 
“overfeeding”, “overeating”, “hypercaloric”, “controlled weight gain” and 11 
“experimental weight gain” limited to English language papers with human subjects. 12 
This was supplemented by manual reference searches: 2272 abstracts were screened, 13 
with 168 articles reporting the effects of hypercaloric diets in humans identified.  14 
This review is limited to describing studies in which hypercaloric diets were used in 15 
an experimental setting in human subjects. No exclusion is made based on the source 16 
of additional energy, however studies that overfed subjects with one macro or 17 
micronutrient but no overall caloric excess are not considered. No exclusions are 18 
made based on participant characteristics or co-morbidity and study design.  19 
In order to assist with direct interpretation of data, the study design, participants and 20 
results from studies meeting the inclusion criteria and assessing current key areas of 21 
interest are described in tables. Specifically, these deal with the effect of overfeeding 22 
on adipose tissue and ectopic fat distribution, adipocyte and metabolic responses 23 
(Tables 1 & 2) and on adipokines, gut hormones and appetite regulation (Table 3). 24 
 25 
Terminology used in the review 26 
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The term fat in this review refers to the dietary macronutrient. Adipose tissue is the 1 
anatomical term for the loose connective tissue, the main cell type being the 2 
adipocyte; adipose tissue also contains the stromal vascular fraction consisting of pre-3 
adipocytes, fibroblasts, vascular endothelial cells and various immune cells including 4 
macrophages. Adipose tissue maybe stored as Subcutaneous Adipose Tissue (SAT) or 5 
as Visceral Adipose Tissue (VAT). Adipocytes are the cells that specialise in the 6 
synthesis and storage of triglyceride, esters composed of glycerol and three fatty 7 
acids. Triglyceride deposition within the liver, i.e. intra-hepatic triglyceride is referred 8 
to as liver fat. Lipogenesis refers to fatty acid and triglyceride synthesis from glucose 9 
or other substrates. 10 
 11 
Lessons learnt from early overfeeding studies  12 
Forty years ago, to understand the biological response of adipose tissue to weight gain 13 
in terms of  hyperplasia (i.e. increased adipocyte number) vs hypertrophy (i.e. 14 
increased adipocyte size), Sims et al conducted a landmark overfeeding study in 15 
inmates at Vermont State Prison4. He studied 5 lean individuals, with no family 16 
history of obesity, and in exchange for early parole subjected them to 10 weeks of 17 
supervised overfeeding while they remained sedentary. They were fed a diet of their 18 
own choice consisting of a three-fold higher caloric intake than would be needed to 19 
maintain body weight, aiming for 15-25% weight gain.  20 
Underlying the significant mean weight gain of 16.2 kg (21% mean increase; ~10.4 21 
kg as fat), was a considerable inter-individual weight change (range, 9-19 kg; 15-25 22 
% increase). Subjects followed their normal routine and their caloric content and 23 
dietary intake was carefully recorded. The findings highlighted that the magnitude of 24 
weight gain could not be predicted from the magnitude of positive calorie balance, 25 
with some individuals protected from, or predisposed to, weight gain through a 26 
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variety of mechanisms. The key finding was that fat mass expansion occurred via 1 
adipocyte hypertrophy (increased cell size) rather than hyperplasia (increased cell 2 
number).  3 
Genetic basis for variations in regional adipose tissue distribution and metabolic 4 
health 5 
Adipose tissue distribution appears intrinsic to the individual and is likely to depend 6 
on heritable factors such as genetic variants, which are likely also subject to 7 
epigenetic regulation. A recent study identified 49 genetic loci associated with waist-8 
to-hip ratio (adjusted for BMI), showing a stronger effect in women. These loci were 9 
enriched for genes expressed in adipose tissue with pathway analysis implicating 10 
adipogenesis, angiogenesis and insulin resistance as processes influencing differences 11 
in distribution5. 12 
Several recent publications have highlighted several specific (common) genetic 13 
variants (particularly those associated with insulin resistance) where there is 14 
dissociation between the body mass index (BMI) and the risk of type 2 diabetes 15 
mellitus (T2DM) or cardiovascular disease (CVD) based on differing body 16 
composition/regional adipose tissue distribution6, 7. Genetic evidence has been 17 
provided for normal weight/lower BMI individuals with a metabolically obese 18 
phenotype, incorporating components of the metabolic syndrome and whose body 19 
composition is characterised by greater hepatic steatosis and increased visceral 20 
adipose tissue (VAT) relative to subcutaneous adipose tissue (SAT) (i.e. lower SAT 21 
capacity). These individuals were at an increased risk of T2DM, coronary artery 22 
disease or hypertension6. Conversely, genetic evidence has been provided for 23 
individuals with higher BMI but lower risk of T2DM, hypertension and CVD. 24 
Presence of such ‘favourable adiposity alleles’ are associated with lower insulin levels 25 
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and a higher SAT:VAT ratio (i.e. higher SAT capacity) 7. The same 1 
genetic/epigenetic factors will also determine the pattern/distribution of adipose tissue 2 
depot expansion during weight gain.  3 
 4 
Conceptual framework for fate of excess energy (Figure 1) 5 
With overfeeding, there are two fates for the surplus energy: either through 6 
stimulation of energy expenditure or deposition in a storage depot (Figure 1A). 7 
However, the majority of excess energy is stored, rather than expended; the amount 8 
stored representing the difference between total energy expended and total energy 9 
ingested. The surplus energy is predominantly stored in adipose tissue (Figure 1B) 10 
with a lesser amount as fat-free mass (Figure 1C). SAT has been described as a 11 
‘metabolic sink’, and once this sink is full, overflow of lipid from SAT to other sites 12 
occurs. The biological properties of subcutaneous adipose tissue, and its response to 13 
overfeeding, govern the distribution of adipose tissue change: upper vs. lower body fat 14 
and subcutaneous adipose tissue (SAT) vs. ectopic triglyceride deposition (as visceral 15 
adipose tissue (VAT), liver and pancreatic fat, intra and intermyocellular fat and 16 
perivascular fat) (Figure 1D). The distribution of excess body fat (whether stored as 17 
SAT, upper or lower body or as ectopic fat) has potentially profound secondary 18 
consequences on metabolic and cardiovascular risk and ultimately on the development 19 
of atherosclerosis.  20 
 21 
Changes in energy expenditure with overfeeding (Figure 1A) 22 
Total energy expenditure (TEE) is composed of resting energy expenditure (REE) 23 
(~60% of total), thermic effects of food and activity energy expenditure (exercise and 24 
non-exercise activity thermogenesis8).  25 
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TEE TEE is stimulated with overfeeding (by ~10%)9 but does not increase linearly 1 
with weight gain10. The extent of TEE stimulation during overfeeding governs the 2 
amount of excess energy stored and thus associated weight gain: individuals with a 3 
lesser tendency to gain weight increase TEE to a greater extent. With ensuing weight 4 
gain, resting metabolic rate will further increase (related to increased body mass) with 5 
recalibration dependent upon the relative changes in adipose tissue volume vs. muscle 6 
mass (skeletal muscle has higher relative energy requirements relative to adipose 7 
tissue)11. 8 
The stimulation of REE also depends upon the macronutrient content of the 9 
overfeeding regime (discussed later) with a hierarchy of macronutrient oxidation; 10 
macronutrients with limited storage capacity are oxidized first. Fat overfeeding has 11 
minimal effect on fat oxidation and total energy expenditure, such that 90-95% of 12 
excess energy is stored, resulting in greater adipose tissue accumulation. In response 13 
to carbohydrate overfeeding, there is stimulation of carbohydrate oxidation and an 14 
increase in TEE with a lower proportion (75-85%) of energy stored 2. Prolonged 15 
overfeeding carbohydrate increases body adiposity by stimulation of de novo 16 
lipogenesis of hepatic and extra-hepatic (adipose tissue) origin. The predominant 17 
effect of protein overfeeding is accretion of lean body mass with the effect of 18 
increasing resting metabolic rate12.  19 
Diet-induced thermogenesis (DIT) DIT, the energy expenditure associated with 20 
metabolising food, is also influenced by both the energy content and the 21 
macronutrient composition of the food ingested: isocaloric amounts of protein, 22 
carbohydrate and fat increase diet-induced energy expenditure by 20-30%, 5-10% and 23 
0-3% of TEE respectively. 24 
 10
Activity energy expenditure (AEE) AEE is composed of energy expenditure related 1 
to spontaneous physical activity and non-exercise activity thermogenesis (NEAT). 2 
Differences in levels of NEAT have a greater impact on TEE than differences in 3 
spontaneous physical activity. Obese individuals tend to undertake less NEAT than 4 
lean individuals, being sedentary by a mean of 2 hours more per day8. NEAT has been 5 
shown to have a role in resistance to weight gain: individual susceptibility to 6 
overfeeding is determined by a variable induction in NEAT. 16 volunteers were 7 
overfed 1,000 calories daily for 2 months, with a mean weight gain of 10lb, but with a 8 
range of 2-16lb. Change in NEAT (kcal/day) was inversely correlated with adipose 9 
tissue gain (kg). Those with a high NEAT response were more protected from obesity 10 
with overfeeding; those with a low NEAT response were more susceptible to obesity 11 
with overfeeding8.  12 
 13 
Storage of excess energy (Figure 1B, C, D) 14 
Weight gain during overfeeding cannot be oversimplified by assuming 3,500 calories 15 
equates to a 1lb/0.45kg change in body weight, even if the energy surplus during 16 
overfeeding is accurately quantified. This erroneous assumption is based upon the 17 
premise that body weight changes reflect primarily loss or gain of adipose tissue 18 
(comprising 87% triglyceride), knowing the energy density of fat to be 9 kcal/g. 19 
Longer term changes in body fat are accompanied by changes in lean tissue whose 20 
metabolisable energy density is significantly less than body fat (4 kcal/g). Increased 21 
lean body mass would increase REE and higher body weight increases the energy 22 
requirement of physical activity. Mathematical models of energy expenditure and 23 
weight change have been developed that reflect the dynamic changes in body 24 
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composition as weight increases; such models only require knowledge of age, height, 1 
body weight, gender and physical activity11.  2 
A number of overfeeding studies have been performed with concomitant assessment 3 
of body composition by DEXA, CT and/or MRI to provide insight into which storage 4 
depot the excess energy is partitioned. Table 1 details the baseline participant 5 
characteristics and overfeeding regime used in overfeeding studies summarising those 6 
using concomitant assessment of body composition (DEXA ± MRI) to determine fate 7 
of excess energy into regional adipose tissue depots, with results summarized in Table 8 
2.  9 
Storage in adipose tissue vs. in lean body mass The concept of energy partitioning 10 
relates to the proportion of excess energy that is directed towards lean tissue vs. 11 
adipose tissue with the energy partition ratio being a non-linear function of body fat. 12 
People with a higher initial body fat have a greater fraction of their weight change 13 
attributable to increases in adipose tissue vs. lean tissue13. 14 
Storage in upper body (abdominal) vs. lower body (gluteofemoral) adipose tissue  15 
The regional distribution of SAT, quantified by DEXA, is critically important with 16 
subcutaneous adipose tissue depots in upper and lower body characterized by 17 
structural and functional differences and therefore associated with different metabolic 18 
risk. Abdominal (i.e. upper body) SAT (ASAT) is characterized by high uptake of 19 
diet-derived fat and a high lipid turnover.  In contrast, gluteofemoral adipose tissue 20 
(GFAT) has a reduced lipid turnover but a high capacity to accommodate lipids 21 
undergoing redistribution 14, 15.  22 
Accumulation of adipose tissue in the upper body (abdominal obesity) is associated 23 
with increased risk of development of insulin resistance, type 2 diabetes mellitus and 24 
higher cardiovascular and total mortality, independent of BMI. Indeed, individuals 25 
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with a normal BMI and abdominal obesity (determined by waist-hip ratio) have a 1 
higher mortality compared with either individuals with a normal BMI without central 2 
obesity or with all overweight or obese individuals (based on BMI)16. Conversely, 3 
accumulation of adipose tissue in the lower body (gluteofemoral obesity) shows 4 
opposite associations with cardiovascular disease and type 2 diabetes mellitus when 5 
adjusted for overall adiposity.  Paradoxically lower body adipose tissue accumulation 6 
is associated with improved cardiovascular and metabolic profiles (protective role) 7 
suggested to sequester lipids that would be destined for ectopic fat deposition17. 8 
Lower and upper body adipose tissue depots show a different response to weight gain 9 
reflecting their different biological characteristics and capacity for lipid 10 
storage/turnover14.  11 
Storage in subcutaneous adipose tissue vs. ectopic fat deposition (visceral adipose 12 
tissue and liver) Subcutaneous adipose tissue (SAT) must undergo expansion to 13 
accommodate increased lipid supply to avoid deposition of lipids/fatty acids in non-14 
adipocyte cells (causing lipotoxicity)18. SAT expansion may occur by two distinct 15 
mechanisms: hypertrophy of existing adipocytes or promotion of differentiation of 16 
pre-adipocytes (hyperplasia).   17 
The adipose tissue expandability hypothesis suggests that the capacity for AT 18 
expansion is determined by functional adipocyte characteristics and their molecular 19 
and biochemical adaptive responses to positive energy balance19. This capacity is 20 
limited and determines the propensity for excess lipids to be orientated to other tissues 21 
i.e. ectopic lipid deposition, with secondary lipotoxicity. Taylor et al., proposed a 22 
large inter-individual variation in the SAT buffering capacity with each individual 23 
having a personal fat threshold20. This means that once the SAT storage capacity is 24 
reached, ectopic triglyceride deposition ensues with associated lipotoxicity and 25 
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metabolic dysfunction (Figure 2).  1 
These concepts of a finite AT expandability, which has large inter-individual 2 
variation, may explain the distinct body composition phenotypes of metabolic healthy 3 
and unhealthy, lean or obese21. Body composition analysis from these individuals 4 
have confirmed that metabolically unhealthy normal weight individuals are 5 
characterised by a low capacity for SAT expandability (low personal fat threshold) 6 
hence their higher lipid deposition in other organs (resulting in a higher VAT:SAT 7 
ratio and higher liver fat)22. Conversely, metabolically healthy obese individuals are 8 
characterised by a high capacity for SAT expandability (high personal fat threshold) 9 
(a lower VAT:SAT ratio and lower liver fat content)21.  10 
Insights from transgenic mice (lacking leptin while overexpressing adiponectin) 11 
demonstrate that massive expansion of SAT is metabolically inert, providing a safe 12 
harbor for potentially toxic lipids, with reduced ectopic deposition (e.g. liver and 13 
visceral adipose tissue) and preserved insulin sensitivity with little/no systemic 14 
inflammation 23. In contrast, a reduced capacity for SAT expansion is associated with 15 
subsequent inflammatory consequences, development of systemic insulin resistance 16 
(IR) and metabolic syndrome (MS), associated with subsequent development of 17 
endothelial dysfunction and atherosclerosis. These findings are consistent with 18 
observations in people with generalised lipodystrophy, who have limited capacity for 19 
subcutaneous adipose tissue storage and consequently develop severe insulin 20 
resistance, NAFLD and dyslipidaemia24. Conversely, the PPARϒ agonists, 21 
thiazolidinediones improve metabolic profiles by promoting a shift in fat distribution 22 
from visceral to subcutaneous fat depots, by stimulating adipogenesis within SAT25.  23 
Dysfunctional adipose tissue remodeling and metabolic consequences 24 
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AT remodeling involves recruitment of adipogenic precursor cells alongside induction 1 
of various other pathways including that of the renin-angiotensin pathway, 2 
angiogenesis and remodelling of the extracellular matrix26. In contrast, SAT 3 
expansion with limited angiogenesis and hypoxia results in secondary changes 4 
involving induction of tissue fibrosis27, adipocyte cell death and enhanced pro-5 
inflammatory cytokine secretion28. During this process there is a phenotypic switch 6 
with an greater infiltration of pro-inflammatory (M1) macrophages relative to the 7 
anti-inflammatory (M2) phenotype29.  8 
A number of overfeeding studies have tested the validity of the adipose tissue 9 
expandability hypothesis by concomitantly examining changes in adipose tissue 10 
(morphology, gene and protein expression), body composition (using DEXA and/or 11 
MRI/1H-MRS) and the metabolic consequences (using oral glucose tolerance test or 12 
euglycaemic clamps) (summarised in Table 2). Thus we are able to simultaneously 13 
examine structural and functional adaptations of the adipocytes coupled with 14 
examination of regional adipose tissue depot expansion and partitioning of 15 
triglyceride into different tissues (SAT vs. ectopic deposition). Such studies have 16 
provided mechanistic insight into how dysfunctional SAT remodeling contributes to 17 
visceral and liver fat deposition (clinically as non-alcoholic fatty liver disease, 18 
NAFLD) and in doing so initiating metabolic dysfunction with development of 19 
components of metabolic syndrome (e.g. abdominal obesity/increased waist 20 
circumference, dyslipidaemia, hypertension, insulin resistance).  21 
Alligier et al. overfed participants an additional daily lipid mixture composed of 70g 22 
(760 kcal) of saturated and monounsaturated fatty acids for 56 days30. Mean body 23 
weight change was 2.5 kg with substantial inter-individual heterogeneity in magnitude 24 
of weight gain and in the relative accretion of subcutaneous vs. visceral adipose 25 
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tissue.  Although the increment in SAT was associated with the increase in body 1 
weight, there was no relationship between the increment in body weight and VAT nor 2 
was there any association between the expansion of SAT and VAT volumes. The 3 
magnitude of the increase in VAT volume was positively correlated with the 4 
magnitude of the post-prandial exogenous fatty acid release in the circulation during a 5 
labelled palmitate test meal. Individuals with a high visceral adipose tissue gain 6 
appear to have reduced induction of expression of SAT genes involved in triglyceride 7 
synthesis and lipid storage30. Although gene expression changes, without concomitant 8 
measurements of protein expression/activity are not conclusive, these observations 9 
would be compatible with a reduced SAT lipid storage capacity in these individuals. 10 
Johannsen et al. noted a greater metabolic decompensation correlated with smaller 11 
baseline SAT adipocyte size which may suggest that adipocyte hypertrophy reflects 12 
impaired adipocyte differentiation when faced with increased fat storage 13 
requirements33. 14 
Testing this hypothesis further Fabbrini et al. overfed obese individuals who were 15 
either metabolically healthy vs. unhealthy31. It was hypothesised that the 16 
metabolically healthy obese (MHO) will be resistant, whereas the metabolically 17 
abnormal (MAO), will be prone to the adverse metabolic effects of overfeeding. The 18 
results demonstrated that metabolically healthy obese, but not metabolically unhealthy 19 
obese, were protected from the adverse metabolic effects from weight gain with no 20 
change in hepatic and peripheral insulin sensitivity or in VLDL-TG secretion rates 21 
with overfeeding. This was related to upregulation of biological pathways and genes 22 
assoicated with AT lipogenesis in MHO, but not in MAO subjects. In contrast, 23 
McLaughlin et al, tested the same hypothesis in obese, insulin-sensitve (IS) vs. obese 24 
insulin-resistant (IR) individuals postulating similarly that the IS subjects would 25 
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demonstrate  a superior adapative adipose cell/tissue and metabolic response32. To the 1 
contrary, they found that IS subjects had greater increases in VAT and liver fat and 2 
decompensation with overfeeding.  3 
The explanation for these discrepant (and possibly counterintuitive) results between 4 
the overfeeding studies in individuals with different baseline metabolic health are not 5 
clear, but may relate to differences in baseline age, BMI and metabolic health, 6 
duration and nature of dietary intervention and the degree of weight gain.  7 
Votruba et  al., also investigated whether baseline insulin sensitivity could predict the 8 
pattern of weight change, hypothesising that insulin resistant individuals would accrue 9 
more abdominal subcutaneous or visceral adipose tissue whereas insulin sensitive 10 
individuals would accrue leg fat. No relationship was found between baseline insulin 11 
sensitivity and the pattern of regional fat distribution in response to overfeeding34.  12 
 13 
Intrinsic factors influencing the response to overfeeding  14 
Twin studies Several twin studies have provided strong evidence that genetic factors 15 
significantly contribute to the individual differences in the sensitivity to alterations in 16 
energy balance. In the Quebec feeding study 12 pairs of monozygotic twins were 17 
overfed by 1000 kcal, six days a week for 84 days with a mean weight gain of 8.1kg 18 
(2.7kg lean body mass). Although the range of weight gain between the twin pairs 19 
was staggering (4.3-13.3kg) with no correlation between the total energy ingested and 20 
weight gained, there was a high degree of concordance of weight gain within each 21 
twin pair. Furthermore there were significant within pair similarities in regional 22 
adipose tissue expansion and the ratio of abdominal to femoral adiposity, suggesting a 23 
strong genetic influence on both the amount and distribution of weight gain with 24 
overfeeding35.  25 
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Family history of type 2 diabetes mellitus (T2DM) Healthy individuals with a family 1 
history of T2DM are predisposed to the adverse effects of overfeeding. The response 2 
to overfeeding was studied in 41 sedentary individuals with and without a family 3 
history of T2DM (FH+ and FH- respectively). FH+ individuals gained more weight 4 
and became more insulin resistant36.  5 
Gender There are clear gender-specific differences in body composition with males 6 
more likely to accumulate central/abdominal fat and females to accumulate 7 
gluteofemoral adipose tissue17. Menopausal status also influences abdominal adipose 8 
tissue distribution with greater visceral adiposity in post versus pre-menopausal 9 
women37. The effects of gender and menopausal status will clearly influence the 10 
effects of overfeeding on regional adipose tissue deposition.  11 
Ethnicity There are clear differences in adipose tissue distribution and phyisology 12 
according to ethnicity with Asians and Afro-Caribbeans having higher truncal fat 13 
mass, lower lean mass and dysfunctional adipose tissue compared with Europeans38-14 
41. Thus, these ethnic groups are more susceptible to obesity-related cardiometabolic 15 
consequences, with incidence rates of type 2 diabetes equivalent to those with a BMI 16 
of 30 kg/m2  occurring at much lesser obesity levels (whether using BMI or waist 17 
circumference) in South Asians, Chinese and African-Caribbeans 42, 43. Overfeeding 18 
experiments with a short-term, high-fat diet in South Asians vs. Caucasians have not 19 
surprisingly shown more profound metabolic decompensation44, 45. 20 
Effect of low birth weight Individuals with a low birth weight, despite their increased 21 
risk of insulin resistance when exposed to a high fat diet, did not differ in their AT 22 
response compared with control subjects46.  23 
Participant characteristics Inter-individual differences in baseline characteristics 24 
explain varying weight change with factors such as low basal metabolic rate, lower 25 
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baseline lipid oxidation (higher respiratory quotient, RQ), lower levels of spontaneous 1 
physical activity predisposing individuals to greater weight gain47. Baseline body 2 
weight and adiposity also determine the magnitude of the weight change and even for 3 
the same increment in energy intake these differ in lean and obese people.  4 
 5 
Extrinsic factors influencing the response to overfeeding  6 
Overfeeding regime characteristics The duration, energy density and the 7 
macronutrient composition of the overfeeding regime influences the response to 8 
overfeeding.  9 
Effects of macronutrients A key consideration is the macronutrient composition of 10 
overfeeding and whether the effects differ depending on whether excess calories arise 11 
from high-fat, high-carbohydrate or a combination of both (discussed earlier within 12 
energy expenditure section). This is particularly pertinent with conflicting public 13 
health messages about the relative merits and perils of high-fat or high-carbohydrate 14 
diets. Two studies characterised the effects of overfeeding with high fat vs. high 15 
carbohydrate diet on energy storage. Both showed comparable weight gain, however, 16 
Horton et al showed overfeeding with excess dietary fat consumption led to greater 17 
relative adipose tissue accumulation than with excess dietary carbohydrate 18 
consumption2. In contrast, Lammert et al found similar degrees of adipose tissue 19 
accumulation with excess dietary fat or carbohydrate consumption; excess 20 
carbohydrates were converted to triglycerides by inducing hepatic and extra-hepatic 21 
lipogenesis2, 48. Two small, short-term studies found fat and carbohydrate overfeeding 22 
had similar effects on liver fat, however comprehensive assessment involving 23 
molecular biology techniques and metabolic end-points is lacking49, 50. Bray et al. 24 
recently compared overfeeding regimes with different levels of dietary protein, 25 
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finding the low protein group showed a greater increase in % body fat, but a decrease 1 
in intrahepatic lipid51. 2 
Influence of dietary fat composition In the LIPOGAIN study Rosqvist et al., overfed 3 
healthy individuals muffins with either polyunsaturated fatty acids (PUFA) or 4 
saturated fatty acids (SFA) and demonstrated distinct effects on the magnitude and 5 
distribution of adipose tissue deposition and on lean tissue52.  With the PUFA diet, 6 
equal amounts of adipose and lean tissue were gained; in contrast, with a SFA diet 7 
four times as much adipose tissue as lean tissue was gained.  8 
Influence of dietary carbohydrate composition There has been interest in comparing 9 
the effects of different sugars on metabolic health, especially given a proposed link of 10 
excess fructose consumption with non-alcoholic fatty liver disease53. A small number 11 
of studies have compared fructose and glucose overfeeding. Two meta-analyses called 12 
for more data but found no difference in either lipid profile or ectopic fat deposits 13 
between different carbohydrate sources 54, 55. 14 
Influence of pattern of feeding The effects of overfeeding differ according to the 15 
pattern of the food intake: overeating by consuming frequent meals (i.e. snacking) 16 
increased the accumulation of intra-abdominal and liver fat whereas larger meals 17 
(with an isocaloric intake) did not56.  18 
 19 
Effects of overfeeding on other tissues/organs.  20 
Skeletal muscle Effects in skeletal muscle have been examined and as in adipose 21 
tissue there is evidence of induction of extracellular matrix remodeling, inflammation, 22 
reduced insulin signaling and insulin resistance28, 57 . 23 
Cardiovascular system Increasing BMI is clearly linked with increasing risk of 24 
CVD58 although individuals with metabolically healthy obesity may have some 25 
protection against it59. Similarly, normal weight individuals who are metabolically 26 
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unhealthy (MUNW) also maybe at increased CV risk16. Cross-sectional mechanistic 1 
data involving detailed body composition and echocardiography shows that 2 
subclinical measures of systolic and diastolic myocardial performance are related to 3 
adipose tissue distribution and metabolic health rather than simply overall adiposity22. 4 
Metabolically healthy individuals, whether lean or obese, with lower VAT and liver 5 
fat have preserved myocardial function compared with lean or obese, metabolically 6 
unhealthy individuals22.  7 
 8 
Effects of overfeeding on gut hormone, adipokines and appetite regulation 9 
Consistent with the concept of a weight ‘set point’, it has been speculated that a 10 
period of overfeeding may be accompanied by subsequent compensatory changes in 11 
peripheral signals from the gut or expanded adipose tissue mass that would help 12 
normalise body weight. Several studies have characterised alterations in circulating 13 
gut hormones, adipokines and the control of appetite after overfeeding (summarised in 14 
Table 3). 15 
Cornier et al., examined activation of key brain regions involved in appetite 16 
regulation, in response to visual food cues (control images, neutral hedonic and high 17 
hedonic value food items e.g. chocolate), using functional MRI. The authors studied 18 
participants after two days of eucaloric energy intake, followed by two days of 19 
overfeeding with 30% excess energy intake consumed. After two days of overfeeding, 20 
visualisation of high hedonic value images elicited lesser activation of these key 21 
appetite-regulating brain regions while after test meals satiety ratings were higher and 22 
hunger ratings lower (using visual analogue scales)60. These findings suggest 23 
homeostatic interactions occurred between overfeeding and subsequent regulation of 24 
energy intake. However, comparing thin and reduced-obese individuals (i.e. obese 25 
 21
individuals who had lost 8-10% of body weight through a weight-loss program), after 1 
overfeeding the neuronal response to high hedonic value images was reduced in thin 2 
but not in reduced-obese individuals61. Similarly, after overfeeding reduction in 3 
hunger ratings and increases in satiety ratings were less in reduced obese versus thin 4 
individuals62.  These findings suggest adaptations in the reduced-obese individuals 5 
that would encourage weight regain.   6 
 7 
Interaction of overfeeding with changes in physical activity  8 
Few studies have examined the interaction of changes in physical activity with 9 
overfeeding. Knudsen et al., implemented a 14 day overfeeding protocol (total energy 10 
intake increased by ~50%) combined with physical inactivity (step reduction to 1,500 11 
steps/day) in healthy young men63. Changes in insulin sensitivity were apparent prior 12 
to changes in body composition measured by DEXA/MRI63. Wahlin implemented a 13 
similar protocol for 7 days, with an overconsumption of 50% excess energy 14 
simultaneously restricting the physical activity to below 4,000 steps, and similarly 15 
noted a dramatic reduction in insulin sensitivity with modulation of key metabolic 16 
genes (e.g. SREBP1c and FAS) and protein expression (GLUT4, AMPK, AKT1 and 17 
AKT2) within adipose tissue64. Significantly, the same short-term overfeeding and 18 
reduced physical activity protocol, with inclusion of 45 min of daily treadmill running 19 
at 70% maximal oxygen uptake, counteracted most of the detrimental effects at a 20 
whole-body and adipose tissue level, despite the provision of additional dietary 21 
energy intake to account for the extra energy expended by exercise64.  22 
 23 
Confounding variables within overfeeding study designs. 24 
This review highlights the numerous overfeeding studies performed; however, 25 
significant heterogeneity in study design, experimental technique and outcome 26 
 22
measures makes direct comparisons between studies difficult. Furthermore, there are a 1 
number of common limitations. Practical and ethical considerations mean that studies 2 
are generally small scale and short-term. Eliminating bias (including observer bias) is 3 
difficult and adjusting for confounding factors including physical activity, participant 4 
compliance and ensuring consistent delivery of overfeeding very challenging. Ideally, 5 
studies should be in controlled environments; however, this raises further technical, 6 
ethical and financial challenges. 7 
 8 
Conclusions and future lines of research 9 
The challenge with the current obesity epidemic is to understand how to facilitate 10 
healthy AT remodeling expansion with hyperplasia, involving adipocyte 11 
differentiation, rather than dysfunctional AT remodeling with hypertrophy, induction 12 
of insulin resistance and inflammation. In doing so we can reduce ectopic fat and 13 
potentially ectopic fat-related complications, T2DM, NAFLD and CVD. Prediction of 14 
personal fat thresholds would help individuals maintain their metabolic health as long 15 
as possible. Despite the numerous overfeeding studies performed, conclusions are 16 
hampered by significant heterogeneity in study design and the limited number of 17 
studies involving a controlled environment. However, such studies are technically and 18 
ethically difficult, with optimal study duration and design unclear, and the issue of 19 
controlling for confounding factors challenging. Considering such limitations, the 20 
fundamental question of adipose tissue, metabolic and cardiovascular responses to 21 
excess calories from fat vs. carbohydrate intake remains a major public health concern 22 
and is a knowledge void that needs filling with carefully designed interventions. 23 
 24 
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Figure legends 
 
Table 1 Overview of feeding studies detailing baseline participant characteristics and 
overfeeding regime summarising those using concomitant assessment of body 
composition (DEXA ± MRI ±CT) to determine fate of excess energy into regional fat 
depots. F Fat; CHO Carbohydrate; NAFLD Non-Alcoholic Fatty Liver Disease. 
 
Table 2 Key studies examining adipose tissue deposition, changes in adipose tissue 
structure/biology and metabolic consequences following overfeeding. IHTG 
Intrahepatic triglycerides; TG Triglycerides; HOMA-IR Homeostatic Model 
Assessment- Insulin Resistance; NEFA Non-esterified Fatty Acids; SAT 
Subcutaneous Adipose Tissue; AUC Area Under Curve; FFA Free Fatty Acids; 
VLDL Very Low Density Lipoproteins; IMCL Intramyocellular Lipids; IS Insulin 
Sensitivity 
 
Table 3 Key studies examining changes in appetite or circulating levels of 
adipokines/gut hormones in response to overfeeding. CHO Carbohydrate; F Fat; P 
Protein; VAS Visual Analogue Scales; fMRI functional Magnetic Resonance 
Imaging; PYY Peptide YY; GLP-1 Glucagon-like peptide-1. 
 
Figure 1 Conceptual framework highlighting potential mechanisms where inter-
individual differences in partitioning of excess energy with overfeeding may arise. 
Inter-individual differences may arise due to A) proportion of excess energy expended 
vs. excess energy stored, B) relative storage in adipose tissue vs. in lean body mass, 
C) relative storage in upper body vs. lower body fat, D) amount of ectopic fat 
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deposition in visceral adipose tissue (VAT), liver or other organs (skeletal muscle, 
heart or pancreas etc.). 
 
Figure 2 The relationship between BMI and insulin sensitivity is not linear as 
suggested by epidemiological evidence. Rather individuals are susceptible to 
metabolic decompensation when their weight exceeds their ‘personal fat threshold’. 
This threshold varies hugely: those with a low ‘personal fat threshold’ are more 
susceptible to cardio-metabolic decompensation with only modest weight gain 
(metabolically unhealthy normal weight) vs. a higher threshold means individuals can 
withstand much greater weight gain without decompensating (metabolically healthy 
obese) (adapted from Taylor et al.20
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Table 1
DEXA 
CT at L2/3, L3/4 and L4/5.
17 non-diabetic males (n=5), 
females (n=11)
Abdominal MRI (T1-
weighted)
(56% with NAFLD) Liver 1H-MRS
NR DEXA 
(range 18-30) Abdominal MRI 
(T1-weighted)
36 healthy men, 4 groups:  140% BL requirement: 
increased meal size (S) or 
frequency (F).
  HFHS-S n=8 22.6±2.9 22.3±1 Two supplements:
  HFHS-F n=8 21.5±1.9 22.5±1.5   High Fat High Sugar (HFHS): 
  HS-S n=10 22±2.5 21.7±1.1 49% CHO, 35% F, 16% P
 HS-F n=10 21.9±2.8 22.6±1.8   High Sugar (HS):
 Commercial sucrose drinks. 
Abdominal MRI (T1-
weighted) 
39 healthy subjects: Abdominal MRI 
  PUFA intervention: 5 women, 13 
men
PUFA: 
26.7±4.6
PUFA: 20.8 
(19.5-23.1)
1H-MRS liver 
20 obese subjects: Abdominal MRI (T1-
weighted) 
  Metabolically normal (MNO; 
IHTG <5.6%) n=12   
MNO: 43±10 MNO: 
34.0±3.0
Liver 1H-MRS
  Metabolically abnormal (MAO; 
IHTG >10%) n=8
MAO: 52±7 MAO: 
35.7±3.9
15 insulin-sensitive 54 ±8 29.3±2.4 Regular diet+ snacks/beverages CT measured SAT, VAT and 
mid-thigh fat
16 insulin resistant 57±6 30.7±2.7 Mean additional calories 880 
kcal/d (50% CHO, 35% fat, 
15% protein)
Liver 1H-MRS
Target weight gain 3.2 kg 
(0.8kg/week)
Liver 1H-MRS
McLaughlin et al 
201632
28 days Free living
Fabbrini et al. 
201531
Regular diet +1000kcal/d 
maintaining macronutrient 
intake. Delivered via specific 
menu choices from fast food 
chains.
Until 5-7% 
weight 
gain; mean 
52 days
Free living
Boon et al . 201567 24 healthy men 22.1±0.4 21.5±0.4 Regular diet +1275kcal/d; 94% 
F
5 days No physical 
activity
Abdominal MRI (T1-
weighted) Liver 1H-MRS
56 days Free living
Rosqvist et al . 
201452
Regular diet + muffins (51% F, 
5% P, 44% CHO) titrate to 
weight gain supplemented with 
polyunsaturated  (PUFA) or 
saturated (SFA) fat  
49 days Usual
Johannsen et al. 
201433
29 healthy men 26.8±5.4 25.5±2.3 1.4X BL energy requirement; 
41% CHO, 44% F, 15% P.
Koopman et al. 
201456
42 days Free living
Step reduction 
<1500 steps/day 
(10278±2399 to 
1521±488)
Knudsen et al. 
201263
9 healthy men 24±3.3 21.6-±2.5 Usual diet + 1500kcal as snack 
packages
56 days
Alligier et al. 
2012,201326, 30
14 days
33±1 Regular diet + 760kcal/d; 91% F 56 days
Tchoukalova et al. 
201014  and 
Votruba et al. 34
28 healthy men (n=15), women 
(n=13)
NR 22.1±0.5 Tailored to achieve 5% weight 
gain
Sevastianova et al. 
201266
Median 54 
(40-59)
30.6±1.2 Normal diet + 1000kcal/d; 98% 
CHO
21 days
Reference Baseline characteristics Mean Age 
(y)
Mean BMI 
(kg/m2)
Overfeeding regime
Van der Meer et 
al.  200865
15 healthy men 25±6.6 23.4±2.5 Normal diet + 2632 kcal/d; 94% 
F
Period
1H-MRS of liver and soleus 
muscle 
  SFA intervention: 6 women, 13 
men
SFA: 
27.1±3.6
SFA: 19.9 
(18.9-20.7)
Pancreatic MRS
44 healthy men
Body composition analysis 
modality
3 days Free living Cardiac and liver 1H-MRS 
Activity
DEXA/Abdominal MRI
Usual
Free living
Free living
Table 2
Changes in SAT Changes in VAT Changes in liver fat Insulin Sensitivity Lipid levels
IHTG: 2.01±1.79% to 
4.26±2.78%
TG 1.3±0.4 to 
2.9±1.1mmol/L
Cardiac TG: 
0.38±0.18% to 
0.4±0.12%)
NEFA 0.54±0.29 to 
0.92±0.33mmol/L
Upper body: Femoral/abdo SAT 
+22.0±2.6% (women) Size (µg lipid/cell):
+41.0±7.3% (men) Abdo: +39±11%
Lower body: Femoral: ±12±8%
+18.2±1.3% (women) No. (x109):
+34.9±5% (men) Upper body: +3±5%
Lower body: +23±7%
1.8±0.3kg TG 1.1±0.11 to 
1.4±0.12; 
(88.7±4.1 to 
90.5±4.1kg)
FFA 424±31 to 
416±38
Lipogenic index 
16:0/18:2n-6 ratio:
TG 2.1 (1.9-2.3) to 
2.6 (2.4-4.1)
VLDL 2.1±-0.3 to 
3.2±0.5
2.5kg Abdominal SAT 
79.1±1.8 to 
81.6±1.8kg
Size (cell surface 
µm2) 3123±129 to 
3120±160
Number (cells/mm2) 
320±16 to 336-±28
1.6kg HOMA-IR 1.1 to 1.6 TG 0.92 (0.64-1.3) 
to 1.13 (0.89-1.43) 
mM
71.3±3.5 to 
72.9±3.4kg
OGTT AUC 
increased 37±10%
FFA 362.5(267.5-
491.2) to 233.4 
(138.5-393.1) µM
Clamp: glucose 
infusion rate reduced 
by 43.6±11%.
Matsuda index 
reduced by 26±14%
POOLED 
HFHS/HS-S:
POOLED HFHS/HS-S: Pooled HFHS/HS-S:
BMI 22.05±0.98 
to 22.75±1.04
0.225±0.06 to 
0.228-±0.056L
0.196±0.068 to 
0.215±0.041L
IHTG: 0.83±0.38 to 
1.00±0.78%
POOLED 
HFHS/HS-F:
POOLED HFHS/HS-F: Pooled HFHS/HS-F:
BMI 22.5±1.5 to 
23.2±1.6
0.276±0.111 to 
0.315±0.115L
0.239±0.073 to 
0.266±0.077L
IHTG: 1.22±0.93 to 
2.18±1.9%
Change in 
weight not 
reported
+7.6±2.1kg IHTG: 1.5±0.6 to 
2.19±1%
Clamp (glucose 
infusion rate):
(81.9±10.3 to 
89.5±-9.4kg)
IMCL: 0.45±0.24% to 
0.49±0.24%
Low dose insulin: 
+18%
High dose insulin: 
+5%
EGP suppression: 
96±10% to 82±20%
PUFA 
1.6±0.85kg (BL 
67.4kg)
Abdominal SAT: 
PUFA +0.25±0.32L 
(baseline: 2.2L)
PUFA +0.11±0.21L 
(baseline 0.99L)
IHTG: PUFA 
+0.04±0.24% (baseline 
0.75%)
HOMA-IR: PUFA 
+0.2±-0.5 (baseline 
1.23)
SFA 1.6±0.96kg 
(BL 63.3kg)
SFA +0.34±0.23L 
(baseline: 1.8L)
SFA +0.22±0.16L 
(baseline: 0.81L)
SFA +0.56±1% 
(baseline 0.96%)
SFA +0.18±0.3 
(baseline 1.04)
MNO: +6%; 
95.8±13.7 to 
101.7±14.4kg
MNO: +2%; (3008±796 
to 3071±809cm)
MNO: +12%; 
885±240 to 
987±295cm3
IHTG MNO: 2.4±1.1 to 
3.9±2.6%
HOMA-IR: MNO: 
+10% (baseline 2)
TG (mg/dl): MNO: 
0% (89±43 to 
89±32)
Hypercaloric diet with 
increased meal 
frequency increased 
intrahepatic fat 
independent of body 
weight gain and caloric 
content. 
Smaller adipocyte size 
associated with a 
greater decrease in 
insulin sensitivity. No 
association between 
adipocyte size and 
ectopic fat
NA
Changes in IHTG and 
VAT associated with 
changes in palmitic 
acid (SFA). Linoleic 
acid (PUFA) inversely 
associated with liver 
fat. 
NA
Rosqvist et al 
201452
NA NA
Fabbrini et al 
201531
Transcriptional 
pathways related to 
lipid metabolism and 
synthesis: upregulated 
Johannsen et al 
201433
Abdominal SAT: 
+1.3kg (4.1±1.5 to 
5.4±1.8kg)
Abdominal VAT: 
+0.36kg (0.58±0.49 
to 0.94±0.58kg)
TG (mg/dL) 87±42 
to 96±68
Knudsen et al 
201263
NA 28.8±13.5 to 
43.1±20.5cm3
NA NA
Koopman et al 
201456
NA Clamp: no change in 
peripheral insulin 
sensitivity.
TG significantly 
increased in HFHS-F 
group only 
(0.56±0.21 to 
0.84±0.32mmol/L)
Reduction in insulin 
sensitivity precedes 
changes in body 
composition.
Increase in liver fat 
proportionate to de 
novo lipogenesis
Alligier et al 
2012,201326, 30
91±7 to 100±7cm3 92±11 to 
102±11cm3
NA HOMA-IR 2.29±0.16 
to 2.44±0.15
FFA (µM) 418±23 
to 355±16
NA
Sevastianova et al., 
201266
4440 (3700-6210) to 
4570 (4000-6280)cm3
2180±300 to 
2290±310cm3
IHTG: 9.2±1.9% to 
11.7±1.9%
NA HOMA-IR 1.7±0.3 to 
1.8-±0.2
BMI increased 
23.4±2.5 to 
23.6±2.5 Change 
in weight not 
reported
NR NR NA HOMA 2.0±1.2 to 
4.9±2.3
Key findingsReference Weight gain (kg) Changes in fat distribution Adipocyte response Metabolic response
NA
Tchoukolava et al 
201014 and 
Votruba et al. 34
4.6±2.2kg +40.5%±5.8 NA 24 Insulin AUC 
Increased by 
2685±6252 (p=0.04). 
NA Abdominal SAT 
adipocyte size 
correlated with upper-
body fat gain. No 
correlation between 
between baseline 
insulin sensitivity and 
upper body SAT or 
VAT gain.
Van der Meer et 
al. 200865
MAO: +6%; 
103±11 to 
109±11.6kg
MAO: +5%; 3145±871 
to 3308±928cm3
MAO: +12%; 
1714±585 to 
1912±645cm3
MAO: 15.2±4 to 
22.8±4.3%
MAO: +22% (baseline 
6)
MAO +27% 
(134±61 to 170±52)
TG (mmol/l): 
1.0±0.1 to 1.0±0.1
IS 86.2±10.1 to 
89.6 ±10.3kg
IS: 147 ± 54 to 162 ± 
51cm3
IS: 37±22 to 
44±28cm3
IHTG: IS: 0.03 ± 0.21 
to 0.07 ± 0.04
Abdominal SAT size 
and structure:
IR 89.4±11.2 to 
92.1±11.1kg
IR: 140 ± 34 to 148 ± 
37cm3
IR: 64±16 to 
73±27cm3
IHTG: IR: 0.23±0.31 to 
0.3±0.22
Peak adipocyte 
diameter increased 
significantly only in IS 
subgroup.
 
NA
Smaller adipocyte size 
associated with a 
greater decrease in 
insulin sensitivity. IS 
rather than IR subjects 
experienced metabolic 
decompensation than 
IS subjects.
Significant decrease in 
percentage of small 
adipose cells in IS 
Clamp: Suppression 
of glucose rate of 
appearance lower in 
MAO group. 
VLDL apoB100: 
secretion increased in 
MAO but not MNO 
(p=0.004)
NA HOMA-IR: 
1.62±0.26 to 
2.39±0.32
NANA IHTG: 1.57±0.27% to 
3.43±0.49%
McLaughlin et al 
201632
Muscle insulin 
resistance worsened in 
IS group only: 
45%(IS) vs.  8%(IR) 
Insulin suppression 
of lipolysis worsened 
significantly in the IS 
subgroup alone 
in metabolically 
healthy but not in 
metabolically 
unhealthy 
Boon et al 201567 69.1±1.9 to 
69.6±1.9kg
NEFA (mmol/l) 
0.5±0.03 to 0.5±0.03
Table 3
Reference Baseline characteristics Mean Age (y) Mean BMI 
(kg/m2)
Dietary protocol Period Activity Weight gain Changes in appetite Changes in gut hormones
13 thin (7 women, 6 
men) and 9 reduced 
obese (RO; 5 women, 4 
men) subjects. 
Thin: 30.6±8 
(women) 
29.3±7.6 
(men).
Thin: 
20.6±1.8 
(women) 
21.3±3 (men).
Not reported VAS: pre-meal hunger reduced in
thin but not RO group following 
OF. Post meal satiety increased in
thin but not RO group following 
OF.
Total not 
reported
Fat mass 
+3.3±1.6kg
Not reported fMRI response to visual food 
cues (high hedonic 
value>neutral hedonic value) 
blunted by overfeeding.
Normal 
weight: 
72.4±9.2 to 
74.5±9.6kg
Overweight: 
77.8±4.2 to 
79.4±4.3kg 
Obese: 
93.0±15.6 to 
95.7±16kg
82.2±1.8 to 
84.4±1.5kg
80.9±1.8 to 
83.1±1.9kg
CT women 
+0.22± 0.18kg 
Controls 
+0.72± 0.26kg
HF/LED: 
+3.2±0.5kg 
HF/HED: 
+6.1±0.8kg 
HC/LED: 
6.5±0.5kg
Ad libitum intake higher on first 
day following OF compared with 
others. Trend towards lower than 
baseline ad libitum intake 
following OF (significant only in 
HF/LED group).
2 days 
eucaloric 
intake, 2 days 
overfeeding
Habitual 
physical 
activity
VAS: decreased hunger and 
increased satiety following 
HF/LED overfeeding only.
Physical 
activity 
tailored so 
energy 
expenditure 
stable over 
study period.
N/A
Not reported N/A
1 week Not reported N/AWadden et al., 
201371
72 healthy young men 
(normal weight n=30; 
overweight n=14; obese 
n=28)
N/A3 arm cross 
over design: 2 
days OF with 4 
days 
measurement of 
ad libitum 
intake
Fasting GLP-1 increased in 
all groups with no difference 
based on weight status
4 weeks Habitual 
physical 
activity
N/A Incremental AUC for PYY 
and GLP-1 unchanged in 
CT group and decreased in 
normal weight group after 
overfeeding. Fasting ghrelin 
increased after overfeeding, 
lower in CT group vs normal 
weight.
Germain et al., 
201472 
8 constitutionally thin 
(CT) women (BMI 
<17.5 with no eating 
disorder or nutritional 
deficiency) and 8 normal 
weight controls
21.6±1.9 vs 
22.1±0.8
17.1±0.3 vs 
22.1±0.3
630kcal excess from fat 
(peanuts, cheese, olive oil, 
butter).
Apolzan et al 20143 15 men and 5 women. 1 
normal weight, 8 
overweight, 11 obese, 
otherwise healthy
34±9 30.7±4.6 140% energy requirements. 
3 diets: High fat/low energy 
density (HF/LED; 
1.05kcal/g; 50% F, 35% 
CHO, 15% P) , high 
fat/high energy density 
(HF/HED; 1.6kcal/g; 50% 
F, 35% CHO, 15% P), high 
carbohydrate/low energy 
density (HC/LED; 
1.05kcal/g; 20% F, 65% 
CHO, 15% P)
23.11 ±0.37 25.27-±0.56 70% more calories than 
required (15% protein, 35% 
fat and 50% carbohydrate
Serum PYY concentration 
significantly increased in 
response to overfeeding
Wadden et al ., 
201270
68 young men (normal 
weight, n=26; 
overweight, n=14; 
obese, n=28)
23 ± 0.4y 25.6 ± 0.6 70% more calories than 
required (15% protein, 35% 
fat and 50% carbohydrate
1 week Not reported
Cahill et al., 201169 69 young men  (normal 
weight, n=27; 
overweight, n=14; obese 
n=28)
Normal 
weight: 
23.7±3.6y 
Overweight: 
22.0±3.1 
Obese: 
23.2±2.6
Normal 
weight: 
22.6±2.6 
Overweight: 
24.1±1.3 
Obese: 
29.1±24.9
70% more calories than 
required (15% protein, 35% 
fat and 50% carbohydrate
1 week 
Fasting serum acylated 
ghrelin increased in all 
groups in response to 
overfeeding
Leptin elevated (+116%)
Cornier et al , 
200761
25 healthy men (n=12), 
women (n=13)
35.6 ± 6.2y 
vs. 33.8 ±4.7y
Habitual 
physical 
activity
N/A2 days eucaloric energy 
intake followed by 2 days 
overfeeding with 30% 
above eucaloric needs 
VAS: reduced hunger and 
increased satiety ratings.
Jebb et al,  200668 6 non-obese men 43.3 ± 10.6 21.9 ± 1.3 Overfeeding periods (+20%,
+40%, +60% energy intake 
with fat) followed by free 
diet periods
3 x 3weeks Food intake stimulated overall 
during free diet period. Variable 
change with ‘compensators’ and 
‘non-compensators’.
21.0 ± 1.3 vs. 
22 ± 1.9
Cornier et al, 
200462
Eucaloric diet for 7 days 
followed by 50% 
overfeeding (50% CHO, 
30% F, 20% P).
7 days 
eucaloric 
intake, 3 days 
overfeeding
Habitual 
physical 
activity
N/A
RO: 38.2±8.3 
(women), 
36.5±7.05 
(men)
RO group underwent 
period of 10% weight 
loss then 4 weeks weight 
stability before study.
Ad libitum energy intake: 
following OF non-significantly 
reduced in all.
RO: 30.4±2.6 
(women), 
27.5±1.8 
(men)


